{"id":"W2529788651","doi":"10.1186/s12895-016-0051-4","title":"Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial","year":2016,"lang":"en","type":"article","venue":"BMC Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":98,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Innovaderm (Canada); Probity Medical Research","funders":"Pfizer","keywords":"Tofacitinib; Janus kinase inhibitor; Medicine; Plaque psoriasis; Dermatology; Janus kinase; Randomized controlled trial; Psoriasis; Pharmacology; Clinical trial; Internal medicine; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003378874,0.0002815551,0.001248807,0.0001093971,0.00009811254,0.000003727792,0.00017613,0.0003739633,0.0001807654],"category_scores_gemma":[0.0001953016,0.0001282949,0.0004993901,0.0001077999,0.0005180755,0.00009454719,0.00003503084,0.00005325073,0.00003671794],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004867692,"about_ca_system_score_gemma":0.0002465079,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005874143,"about_ca_topic_score_gemma":0.0001157788,"domain_scores_codex":[0.9961405,0.002057766,0.001076904,0.000361069,0.00006297743,0.0003007763],"domain_scores_gemma":[0.9969816,0.001626771,0.0006815186,0.0005695415,0.00009940395,0.00004118131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.905959,0.004419148,0.01218823,0.00002510346,0.001188869,0.00001881529,0.0004155458,0.000001117416,0.0116216,0.003066867,0.00009844446,0.06099723],"study_design_scores_gemma":[0.7532409,0.004363525,0.0006714063,0.00003593727,0.0007457648,0.0001961843,0.00006433647,0.000006259413,0.2381992,0.000233883,0.002091548,0.0001510016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951311,0.0004791678,0.0008358072,0.0002677306,0.001160486,0.001754575,0.0001680525,0.00003571637,0.0001673485],"genre_scores_gemma":[0.9986967,0.0001580057,0.0003986858,0.00001573805,0.0000698441,0.0003009236,0.00009871875,0.00001793488,0.0002434488],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2265776,"threshold_uncertainty_score":0.5231715,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04656576236925047,"score_gpt":0.3201715320557242,"score_spread":0.2736057696864738,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}